CN109385410A - Bite the RNA polymerase termination sequence and its identification method and application of Jun body Syn5 in ocean - Google Patents
Bite the RNA polymerase termination sequence and its identification method and application of Jun body Syn5 in ocean Download PDFInfo
- Publication number
- CN109385410A CN109385410A CN201811067462.XA CN201811067462A CN109385410A CN 109385410 A CN109385410 A CN 109385410A CN 201811067462 A CN201811067462 A CN 201811067462A CN 109385410 A CN109385410 A CN 109385410A
- Authority
- CN
- China
- Prior art keywords
- transcription
- syn5
- rna polymerase
- rna
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
The invention discloses RNA polymerase termination sequences and its identification method and application that Jun body Syn5 is bitten in ocean, belong to microbial nucleic acids metabolic enzyme technical field.The termination sequence contains at least one ATCTGT sequence units.Identification method is to be inserted into foreign gene at the multiple cloning sites of carrier, and the promoter sequence in the carrier is replaced with Syn5 promoter sequence, obtains recombinant vector;The recombinant vector is transcribed in vitro, it recycles the RNA product other than the RNA of overall length transcription and carries out 3 ' RACE sequencing, corresponding termination sequence contains at least one ATCTGT sequence units and contains at least one ATCTGT sequence units to get to bacteriophage Syn5RNA polymerase transcription termination sequence.The transcription terminator can be applied to RNA synthetic biology.The present invention identifies single subunit RNA polymerase transcription terminator of marine bacteriophage Syn5, compensates for currently to the deficiency of Syn5RNA polymerase transcription characteristic research, identifies the current most simplified sequence units for causing polymerase that termination is transcribed in vitro.
Description
Technical field
The invention belongs to microbial nucleic acids metabolic enzyme technical fields, and in particular to bite the RNA polymerase of Jun body Syn5 in ocean
Terminator and its identification method and application.
Background technique
RNA (ribonucleic acid) polymerase be using RNA or DNA (DNA) be template using nucleoside triphosphate as
Substrate synthesizes the enzyme of RNA, is the synthetics of RNA.RNA is the carrier of hereditary information transmitting, is widely present in eucaryote, original
In core biology, fractionated viral and viroid, have the function of numerous species and.Except previous well known three categories RNA:mRNA, rRNA
And outside tRNA, Recent study find some novel RNA such as microRNA (miRNA) (Mohr and Mott., 2015),
long non-coding RNA(lncRNA)(Dey et al.,2014)、Circular RNAs(circRNA)(Memczak
Et al., 2013) etc. key effect is all played in different physiological processes.With deepening continuously for RNA correlative study, RNA
Application value in terms of disease treatment is also increasingly shown.Be delivered to after synthesizing in vitro by design mRNA sequence intracellular
It can be translated as any target protein, and mRNA translation is quickly, automatic degradation, the advantage compared to DNA can existed in vivo
In will not be integrated into host genome, and work faster.In addition to being used as vaccine, mRNA drug also can be used as pharmaceutical grade protein supplement
Or alternative medicine, treat other a variety of diseases.Currently, the technologies such as mRNA modification and preparation also achieve quantum jump, solve
The stability and delivery problems of mRNA, this makes mRNA drug become a kind of ideal medicament forms, mRNA pharmaceutical industry
Also increasingly mature, the drugmakers such as Moderna, BioNTech and CureVac have all formed mRNA drug products line abundant.It removes
Outside mRNA, RNA interference (RNAi) is carried out to target gene using double-stranded RNA and utilizes the gene editing of gRNA guidance
(CRISPR gRNA) technology etc. all has preferable prospect in disease treatment.
The development of RNA correlative study and application proposes very high challenge to RNA external preparation, and traditional chemical synthesis side
Method is only limitted to tens nucleotide length below of synthesis, also steeply rises when length increases cost.However it is designed to encode
The mRNA of protein generally reaches thousands of a nucleotide, it is clear that this method is no longer applicable in, and can only carry out body by RNA polymerase
Outer transcription is to synthesize RNA.Although RNA polymerase is many kinds of, the RNA polymerase of most of organisms all has complicated Asia
Base composition and regulatory mechanism, are not suitable for use in the external synthesis machine of RNA.1970s scientists find that one kind comes from
Single subunit RNA polymerase of Escherichia coli T7 bacteriophage, structure simply have specific transcription (identifying special promoter)
The features such as high with transcriptional efficiency, 1984 by a time cloning after be just widely used in external synthesis, the expression of recombinant protein of RNA
(the high expression system of bacterium) etc. (Davanloo et al., 1984) becomes the unique method of external synthesis long-chain RNA, in biology
Chemical research and RNA synthesis field have a wide range of applications.The bacteriophage T3RNA polymerase and SP6 RNA of subsequent discovery are poly-
Synthase is all relatively close with T7 RNA polymerase affiliation and has similar property, with the continuous hair of the external synthesis application of RNA
Exhibition and deeply, this kind of list subunit RNA polymerase all shows many very important disadvantages, including product end is inhomogenous, right
Starting base has stronger Preference, incorporation modified nucleoside acid low efficiency, and transcription can generate many interruptions rich in higher structure RNA
Product etc. (Lyakhov et al., 1998;Chamberlin and Ring, 1973), cause to synthesize in many cases
RNA is unable to satisfy the requirement of follow-up study and application.
Although scientists are subsequent to have carried out many transformations around T7 RNA polymerase, there is no obtain for its major defect
To improvement, it is increasingly becoming the factor of limitation this popular domain research and development of RNA.Facts proved that due to early stage identification
Bacteriophage type is limited, this fermentoid is not the external synthetics enzyme of optimal RNA.With molecular biology research in recent years
With flourishing for sequencing technologies, discloses marine microorganism quantity and type is very huge, more and more novel bacteriophages
It is found, wherein many novel enzyme instruments may be contained.One of the main inventive people of this patent doctor Zhu Bin is in Harvard
University Medical College studies marine bacteriophage Syn5 during working, and host is the most cyanobacteria of ocean mileage amount.
By killing in ocean 20% biomass, bacteriophage Syn5 plays a significant role in maintaining marine environment energy balance
(Pope et al.,2007).By with t7 rna polymerase gene carry out similitude compare, protein purification and characterization analysis
The methods of, doctor Zhu Bin identifies completely new single subunit RNA polymerase (the Zhu et from marine bacteriophage Syn5
al.,2013).It is compared to T7 RNA polymerase, this enzyme from ocean can be dense in a larger range of temperature and salt
The synthesis of RNA is catalyzed under the conditions of degree, transcription extension ability also greatly improves, also no very stringent to base is originated after promoter
Limitation.The biggest advantage is to can carry out accurate overall length transcription and keep the uniform of product end for Syn5 RNA polymerase
Property (Zhu et al., 2014;Zhu et al.,2015;US patent WO2015024017).Syn5 RNA polymerase is captured
The bottleneck that T7 RNA polymerase is encountered in biosynthesis field, Harvard University has been Syn5 RNA polymerase application Liang Xiang state
Border patent.Currently, Syn5 RNA polymerase shows very big prospect in synthetic biology application.
Although Syn5 RNA polymerase transcriptional promoter sequence and transcription extension property etc. be studied it is fully aware of,
But its tanscription termination characteristic is also not well known.Tanscription termination is also re-recording system as extending with transcription initiation with transcription
Important component, it is particularly significant to the yield and length of control transcription product in the application.In the feelings for not knowing transcription terminator
Under condition, some negative effects may be generated to the external synthesis application of Syn5 RNA polymerase.In protein expression system, Bu Nengyou
The tanscription termination of effect not only can largely reduce outside the transcriptional efficiency of target gene, also will affect the expression water of downstream components
It is flat, such as antibiotics resistance gene, plasmid copy number control element or the inhibition albumen for reducing background expression level
(Mairhofer et al.,2015).So far, still not related to the termination performance of the RNA polymerase of bacteriophage Syn5
Research report.
Summary of the invention
The present invention is directed in the prior art there has been no the termination sequence of the RNA polymerase of bacteriophage Syn5, provides phagocytosis
Body Syn5 RNA polymerase transcription terminator and its identification method and application.
It is according to the invention in a first aspect, provide a kind of marine bacteriophage Syn5 RNA polymerase transcription terminator,
The termination sequence contains at least one ATCTGT sequence units.
It is another aspect of this invention to provide that providing the marine bacteriophage Syn5 RNA polymerase transcription terminator
Identification method contains following steps:
(1) foreign gene is inserted at the multiple cloning sites of carrier, and the promoter sequence in the carrier is replaced with
Marine bacteriophage Syn5 promoter sequence obtains recombinant vector;The recombinant vector is subjected to digestion using restriction enzyme,
The recombinant vector linearized;
(2) the outer responsive transcription system of construct, the in-vitro transcription reaction system is with the recombination of step (1) linearisation
Carrier is as template, using bacteriophage Syn5 RNA polymerase as RNA polymerase, with tetra- kinds of nucleosides three of ATP, GTP, CTP and UTP
Phosphoric acid makes the outer responsive transcription of the recombinant vector generating body of the linearisation as raw material;DNA enzymatic is added to eliminate as template
The recombinant vector of linearisation, the RNA product that then purifying transcription obtains;
(3) the RNA product for obtaining step (2) carries out gel electrophoresis, the RNA product other than the RNA of recycling overall length transcription
And 3 ' RACE sequencing is carried out, the corresponding termination site of RNA product other than the RNA of the overall length transcription contains at least one
ATCTGT sequence units contain at least one ATCTGT sequence to get to marine bacteriophage Syn5 RNA polymerase transcription terminator
Column unit.
Preferably, step (1) carrier is pET28b, and step (1) restriction enzyme is restriction enzyme
BglII。
Preferably, step (2) time that reaction is transcribed in vitro is 1h-2h.
Preferably, the concentration in responsive transcription system is 1 μ to step (2) the bacteriophage Syn5 RNA polymerase in vitro
Μ-2μΜ。
Preferably, the concentration in responsive transcription system is 20ng/ to the recombinant vector of step (2) described linearisation in vitro
ul-40ng/ul。
It preferably, further include RNase inhibitor in step (2) the in-vitro transcription reaction system.
It preferably, further include Tris-HCl buffer, MgCl in step (2) the in-vitro transcription reaction system2, sub- essence
Amine, dithiothreitol (DTT) and pyrophosphatase.
Exist it is another aspect of this invention to provide that providing the marine bacteriophage Syn5 RNA polymerase transcription terminator
Application in RNA synthetic biology.
Preferably, the application is that the bacteriophage Syn5 RNA polymerase transcription terminator is inserted into transcription templates
It is in transcription templates by the bacteriophage Syn5 RNA polymerase transcription terminator to terminate responsive transcription or the application
Same sense mutation is carried out to continue responsive transcription.
In general, through the invention it is contemplated above technical scheme is compared with the prior art, mainly have below
The utility model has the advantages that
(1) present invention express and has been purified to single subunit RNA polymerase from marine bacteriophage Syn5, it is therefore an objective to
Its transcription terminator is identified, efficient transcription terminator element is obtained.The present invention identifies marine bacteriophage Syn5's
Single subunit RNA polymerase transcription terminator is compensated for currently to the deficiency of Syn5 RNA polymerase transcription properties research, is identified
One current most simplified sequence units for causing polymerase that termination is transcribed in vitro.
It (2), not only can be high during the Syn5 RNA polymerase transcription terminator of identification being applied to in-vitro transcription
The termination for precisely transcribing of effect;And on the other hand, the bacteriophage Syn5 RNA polymerase is turned in transcription templates
It records termination sequence and carries out same sense mutation to continue responsive transcription.
(3) Syn5 RNA polymerase transcription terminator of the present invention is sequence-specific terminator, rather than is structure
The terminator of dependent form, therefore can be neatly using the continuation for terminating either responsive transcription for transcription.
Detailed description of the invention
Fig. 1 show the purification effect figure of SDS-PAGE electrophoresis detection Syn5 RNA polymerase in embodiment 1, wherein M generation
Table albumen Marker.
Fig. 2, which is shown, to be transcribed in vitro using T7 RNA polymerase and Syn5 RNA polymerase in embodiment 2
Terminate result figure;The top is the RNA product of overall length transcription, and lower section is the RNA product terminated in advance.
Fig. 3 (a) is that Syn5 RNA polymerase transcription terminator sequences are applied to the result in being transcribed in vitro in embodiment 3
Figure;The transcription termination efficiency of swimming lane 2- swimming lane 6 in corresponding diagram 3 (a) shown in Fig. 3 (b).
Specific embodiment
In order to make the objectives, technical solutions, and advantages of the present invention clearer, with reference to the accompanying drawings and embodiments, right
The present invention is further elaborated.It should be appreciated that described herein, specific examples are only used to explain the present invention, not
For limiting the present invention.As long as in addition, technical characteristic involved in the various embodiments of the present invention described below that
Not constituting conflict between this can be combined with each other.In the situation for not departing from the present invention above-mentioned technical idea and disclosed spirit
Under, according to ordinary skill knowledge and customary means, various equivalent, replacements, modification or change are made, the present invention is both fallen within
The range of protection.
The amplification of embodiment 1:Syn5 rna polymerase gene and protein expression and purification
(1) Syn5 rna polymerase gene and protein expression are expanded
PCR amplification obtains Syn5 rna polymerase gene, and gene order is cloned into the enzyme of prokaryotic expression carrier pET-24a
Between enzyme site NdeI and NotI, in the DNA fragmentation of 33 bases longs of gene 5 ' terminal fusion, described in DNA fragmentation coding
Company flexible is kept between histidine tag and label and Syn5 RNA polymerase as shown in SEQ ID NO:1 in sequence table
Peptide fragment is connect, joining peptide sequence is Gly-Gly-Gly-Gly-Gly.Syn5 rna polymerase gene sequence is shown according to existing research
Column region contains the specific promoter sequence of its transcription identification, thus base sequence progress same sense mutation (is not changed coding
Amino acid), the gene order in carrier pET-24a is finally inserted into as shown in SEQ ID NO:2 in sequence table, the weight that will be built
Group carrier Transformed E .coli BL21 (DE3) express bacterial strain, choose bacterium expand culture, by bacterium be placed in containing 50ug/ml card that LB train
37 DEG C of shaking table cultures are supported in base to OD600The isopropyl-beta D-thio galactopyranose of 0.5mM final concentration is added close to 1.2 in value
Glycosides (IPTG) is in 28 DEG C of shaking table inducing expression 3h.
(2) Syn5 RNA polymerase is purified
Bacteria lysis: after IPTG inducible protein expression 3h is added, 4 DEG C, 5000rpm is centrifuged 20min, removes supernatant and collects bacterium
Body precipitating, thallus is sufficiently resuspended in containing 20mM Tris-HCl (pH7.5), 2M Nacl, 0.5mg/ml lysozyme, 0.5mM
In the lysate of DTT, protein lysate is then frozen in -80 DEG C, to be solidified be placed on melts 1h on ice, then be placed in -
80 DEG C of multigelations are twice.Protein liquid is placed in high-speed refrigerated centrifuge 4 DEG C, 35000rpm centrifugation 1h, after centrifugation in separation
Clearly, the supernatant isolated is passed through to the membrane filtration in 0.45 μm of aperture, further to remove impurity, filtered protein liquid can
Carry out subsequent ni-sepharose purification or 4 DEG C of of short duration preservations.
Ni-sepharose purification: prepare containing 20mM Tris-HCl (pH7.5), 2M NaCl elution buffer, separately configure 20mM,
The imidazole solution of tri- kinds of concentration of 50mM, 100mM is spare.Nickel column is balanced using the elution buffer of 10 times of nickel column packing volumes, so
Afterwards will before filtered protein lysate be added in nickel column, flow out the liquid in nickel column by gravity, in next step according to
Column is crossed by the imidazole solution that the sequence of low concentration to high concentration is gradually added 20mM, 50mM, 100mM, elutes non-specific binding
Foreign protein and final eluting the protein competition in conjunction with nickel column.The protein liquid that each concentration elutes needs to use
Several clean cryopreservation tubes save, and finally detect all protein liquids eluted by SDS-PAGE electrophoresis, select
The Syn5 RNA polymerase of higher degree is saved in 4 DEG C.
Phosphocellurose column chromatography: albumen is added in phosphocellurose column, is prepared and is contained 20mM potassium dihydrogen phosphate
(pH7.5), 1mM DTT, 1mM EDTA, 10%glycerol, 20mM KCl start buffer and contain 20mM di(2-ethylhexyl)phosphate
Hydrogen potassium (pH7.5), 1mM DTT, 1mM EDTA, 10%glycerol, the elution buffer of 1M KCl are spare, use start buffer
5-10 column volume is balanced, salt ionic concentration (by 0.02M KCl to 1M KCl) progress is continuously improved in a manner of continuously eluting
All liquid eluted are carried out Coomassie brilliant blue detection by elution, and the protein liquid that color becomes blue passes through SDS-PAGE electrophoresis
It is detected, Syn5 RNA polymerase about is eluted out in the high salt concentration of 700mM, collects albumen.
Gel permeation chromatography (molecular sieve): by albumen obtained in the previous step with super filter tube (Millipore) be concentrated to 1ml with
It is interior, then using 200ml gel filtration prepacked column Superdex 200 carry out gel permeation chromatography, prepare in advance containing
The elution buffer of 20mM Tris-HCl (pH 7.5), 2M NaCl, 0.5mM DTT, 0.5mM EDTA are balanced with the buffer
After 2 column volume of molecular sieve, albumen is added in column, starts to be eluted with eluent after protein liquid fully enters filler,
The flow control eluted using peristaltic pump collects elution albumen with automatic collector, by all liquid eluted in 1ml/min
Body carries out Coomassie brilliant blue detection, and the protein liquid that color becomes blue is detected by SDS-PAGE electrophoresis, the purity collected
Higher protein liquid.
Albumen dialysis: the protein liquid that gel permeation chromatography is obtained is dialysed after appropriate volume is concentrated by ultrafiltration,
Then plastics clamp opening is added in bag filter in albumen, bag filter is placed in 1L and contains 100mM NaCl, 50mM Tris-HCl
(pH 8.0), 0.1mM DTT, 0.1mM EDTA, 50% glycerol dialyzate in, be placed on magnetic stirring apparatus using magnetic bead stir
Promote solution exchange, dialysis 3h or more replaces clean dialyzate, then proceedes to dialysis 3h or more, and finally replacement dialyzate is saturating again
Overnight, albumen is placed in -20 DEG C of preservations after collecting dialysis for analysis.
(3) SDS-PAGE electrophoresis detection Syn5 RNA polymerase purification effect
SDS-PAGE electrophoresis is carried out after dialysis, then using coomassie brilliant blue staining to the Syn5 RNA polymerase after dialysis
Purity detected, as a result as shown in Figure 1, it can be seen that protein band is relatively simple after dialysis, illustrate Syn5 RNA polymerize
The purity that enzyme obtains after the above purification step is higher.
Embodiment 2: it is transcribed in vitro using T7 RNA polymerase and Syn5 RNA polymerase
(1) acquisition and purifying of responsive transcription template
PCR amplification NrsPOL gene is cloned into the length for increasing carrier in the multiple cloning sites of carrier pET28b, obtains
After recombinant vector, the T7 promoter sequence in carrier is substituted for Syn5 promoter sequence, is finally built into two containing difference
Then the recombinant vector of transcripting promoter is linearized using the restriction enzyme BglII before promoter, use
Purification kit DNA Clean&ConcentratorTM- 5 (being purchased from ZYMO RESEARCH biotechnology company) are to linearisation DNA
Product is purified.
(2) reaction is transcribed in vitro
Except RNA polymerase and transcription templates, other ingredients are consistent in in-vitro transcription reaction system, including 40mM Tris-
HCl (pH7.9), 6mM MgCl2, 2mM spermidine, 10mM DTT, 200 μ Μ ATP, GTP, CTP, UTP, the inhibition of 0.3ul RNA enzyme
Agent, 0.2ul pyrophosphatase mend DEPC water to 10ul.Template containing T7 promoter and Syn5 promoter is separately added into final concentration 1
μ Μ t7 rna polymerase and 2 μ Μ Syn5 RNA polymerases linearize the final concentration of 20ng/ul of transcription templates.By T7 transcription
System and Syn5 transcription system are respectively placed in 37 DEG C and 30 DEG C reaction 2h.2ul RQ1RNase- is then added in the reaction system
Free DNase (Promega) eliminates linearisation template, finally uses RNA Clean&Concentrator in 37 DEG C of reaction 1hTM-
5 (ZYMO RESEARCH) purifying RNA products.It configures 2% agarose gel and electrophoresis is carried out to RNA product, dyed using EB, as a result
As shown in Figure 2.As shown in Figure 2, the RNA production that transcription is terminated except acquisition in T7 transcription terminator is carried out using t7 rna polymerase
Beyond the region of objective existence, there is also apparent overall length transcription products.Transcribed to obtain the site terminated at two, position using Syn5RNA polymerase
After T7 termination sequence on pET28b carrier, Syn5 RNA polymerase is not sent out at the T7 transcription terminator with loop-stem structure
Raw tanscription termination, in addition equally exists the RNA of part overall length transcription.Syn5 RNA polymerase is generated on pET28b carrier
Termination site T1 and T2 carry out 3 ' RACE sequencing, the sequence such as SEQ ID NO:3-7 institute that termination site T1 is sequenced at two
Show, for the sequence that termination site T2 is sequenced as shown in SEQ ID NO:8-12, finally found that through sequence alignment leads to Syn5
The key core sequence that RNA polymerase terminates is ATCTGT.
Embodiment 3: Syn5 RNA polymerase transcription terminator is applied to be transcribed in vitro
(1) acquisition and purifying of responsive transcription template
Syn5 rna polymerase promoter sequence is inserted at 422 position of pUC19 carrier sequence, obtains recombinant vector
Afterwards, it is in addition inserted into CATCTGTTTTTTTT, CATCTGTTTTTTTT respectively at 1500 position of sequence on the basis of the carrier
(existing research behind terminator the result shows that add for X2, CATCTGTTTTTTTT X3, ATCTGT X3, ATCTGT X6 base sequence
T is improved effect to efficiency is terminated), 6 kinds of recombinant vectors are obtained, line is carried out to plasmid template using restriction enzyme NdeI
Property, linearize product purification kit DNA Clean&ConcentratorTM- 5 (ZYMO RESEARCH) are purified.
(2) reaction is transcribed in vitro
The system of reaction is transcribed in vitro are as follows: 40mM Tris-HCl (pH7.9), 6mM MgCl2, 2mM spermidine, 10mM
DTT, 200 μ Μ ATP, GTP, CTP, UTP, 0.3ul RNase inhibitor, 0.2ul pyrophosphatase, 2 μ Μ Syn5 RNA polymerization
Enzyme, 20ng/ul transcription templates mend DEPC water to 10ul.Reaction system is mixed takes 1ul to transcribe after being placed on 30 DEG C of transcription 2h
The laggard row agarose gel electrophoresis detection of sample-loading buffer of formamide and EDTA configuration is added in product, as a result as shown in figure 3, making
It is imitated with VisionWorks software statistics band gray value and according to the termination that each swimming lane reaction is calculated in RNA primer size
Rate.Fig. 3 (a) is that Syn5 RNA polymerase transcription terminator sequences are applied to the result figure in being transcribed in vitro in embodiment 3;Swimming
Road 1 is the pUC19 carrier transcription result for being only inserted into Syn5 rna polymerase promoter sequence, and swimming lane 2 to swimming lane 6 is respectively to carry
Be additionally inserted at 1500 base of body CATCTGTTTTTTTT X1, CATCTGTTTTTTTT X2, CATCTGTTTTTTTT X3,
The transcription result that ATCTGT X3, ATCTGT X6 base sequence obtain;The top band is DNA template, and lower section band is RNA production
Object;The transcription termination efficiency of swimming lane 2- swimming lane 6 in corresponding diagram 3 (a) shown in Fig. 3 (b).By Fig. 3 it is known that swimming lane 6 is being inserted into
When 36 base sequences of ATCTGT X6, Syn5 RNA polymerase transcription termination efficiency highest has reached nearly 95% termination effect
Rate terminates efficiency and significantly improves, illustrate only to pass through raising compared to the CATCTGTTTTTTTT X3 and other base sequences of insertion
The number of repetition of insertion ATCTGT can further increase termination efficiency in the case where introducing less base quantity.
<110>Central China University of Science and Technology
Huazhong Tech Univ Inst., Shenzhen
<120>the RNA polymerase termination sequence and its identification method and application of Jun body Syn5 is bitten in ocean
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 11
<212> PRT
<213>artificial sequence (Artificial Sequence)
<400> 1
His His His His His His Gly Gly Gly Gly Gly
1 5 10
<210> 2
<211> 2370
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 2
catcaccatc accatcacgg cggaggtgga ggctccttcg atctcatcgc tcgccagctt 60
cagcgtgaga ccgaggccgc ggagctggcc cgcaagcgtc tacaagacgc ccgacgcgag 120
gccaatgaac gctcctatgc ctcaagcaac atcgagagcc gcaaggccat cgcgacgttc 180
ctggatccca tcgcccaacg catcggcgaa cgcctgttca cgctacggcg tggtactggt 240
gcagttgatg ccgccgaggt ctacaagcat ctgaagaacg ccgatcacca tcatctggcg 300
ctcatcacga tgaagacagc cctggacgtc ctgggcaaag atcccgagcc acagatccaa 360
cagctgacca cagccattgg ccgcaacatc cagctggagc tccgcctcac gtactacgcc 420
gaggaaaacc cggagctcta caaacaggcc tcccgcttct tccacgcagg cactggcacc 480
cgccagaaag ccacggtgat caaactcaag ttcaaccgcg agggcattga gtgggaccaa 540
tggtcccgcg tcacctgtca caaggttggc caatggctca tgttggctat ggccgacgtc 600
accggctgga ttgaacgggc aaccgaccga accagtggag gacgcaaaac caagacccgc 660
atctgctact cccgcgagtt cttgcagcat cgggacacaa tcctcgcagc agctgagcag 720
ttggccttct gccagtggcc catgctttgc cctcccattg agtggtccaa cgaccacaac 780
ggtgggtacc tgagcgaaca gatccggcgg gtcaatccgc tgattcgtaa aacgggtcca 840
ttgggcaccc gtaagcaagg agacataccc cttgcgatgc tcaacaacct gcagggtcag 900
gcctacaagg tcaaccctga agttctcgac atagcgaacc actgctacga gtccaacgtg 960
accgtaggca agttcatacg ccacgctccc ctacctgttc caccatcacc cggtgaggac 1020
tgtacagagg accagctcac agcctataaa cgggcacgac gtgaggccga ggacttcaac 1080
gcacagatca gtcagaagaa ctggcgcacg accgaggtca tgtatgtggc ccgcaagtac 1140
gccgacgagg cctccttctg gatgcccgcc agcttcgact atcgcggccg tgtttacttt 1200
ctgaacactg ccctcaaccc gcaggggact gacttcgaca aggcgctcct ttacttcgct 1260
gaggagggtc cggtcaacga atggtggcta tccttccacg tcgcgaccac ctacggcctc 1320
gacaaggaga ccatggtcaa ccgggtccaa tgggctcggg acaaccacga gctcatcgat 1380
cgcatcgcct ctgaccccgt ccgccatacc gagtggcacg acgctgacga gccctggtgc 1440
ttcctggctg cctgcctcga gtacaaggcc tgcgtgatcg atggcaccaa acagaccagc 1500
ggcctcccta tcgggatcga cgccacctgt tcaggcctgc agcacctcgc tgctatgacc 1560
cgctgcggac gcacagccgc cctggtcaac gtgacaccga ccgacaagcc ggccgatgct 1620
tacaagaccg tggcgcaagc atccctcaag catctcccca aggagcagca cgagtggatc 1680
acccgcaagg tcaccaaaag gcccgtcatg tgcacaccct acggggtgac catgtcatcg 1740
gcccgcggct acatccgcga tcagctggtg aaggacggcc acaaggagga cctccgatct 1800
cctggcgtgc tcaacggcat cgtcaaggcg atctttaatg aggccatccc tgaggtcatc 1860
cccggccccg tgcaggtcat ggcctggctc aagcgttcag ctggtcagat catcgaccgg 1920
ggtgattcca ccatcacgtg gaccacgccc tcaggcttcg aggttgttca agacctcaaa 1980
aagtccaaga cctacgaggt caagacccgc atcatgggcg gagcacggat caagctccaa 2040
gtgggcgacg ggttcaccga cgagcccgac cgtgaccacc acaaaagcgc actggctccc 2100
aacgtggtgc acagcaacga tgcgtctctc ctccacctga ccttcgcctt ctgggacaag 2160
cccttcacgg tcatccatga ctgtgtcctg ggccgttcct gcgacatgga tcagatgggc 2220
tccgacatcc ggcttcattt cgccgagatg tacaaggccg acgtgatgca agactgggcc 2280
gaccaggtgg gcgttgagct ccctgtcgac ctgatcaaaa acacgctcga catcgacagc 2340
gtcaaccagt ccctttactt cttctcctga 2370
<210> 3
<211> 14
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
atctgtaaca tcat 14
<210> 4
<211> 14
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
atctgtaaca tcat 14
<210> 5
<211> 14
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 5
atctgtaaca tcat 14
<210> 6
<211> 19
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 6
atctgtaaca tcattgaac 19
<210> 7
<211> 14
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 7
atctgtaaca tcat 14
<210> 8
<211> 15
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 8
atctgtgcgg tattt 15
<210> 9
<211> 15
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 9
atctgtgcgg tattt 15
<210> 10
<211> 17
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 10
atctgtgcgg tattttt 17
<210> 11
<211> 16
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 11
atctgtgcgg tattcc 16
<210> 12
<211> 18
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 12
atctgtgcgg tattttgc 18
Claims (10)
1. marine bacteriophage Syn5 RNA polymerase transcription terminator, which is characterized in that the termination sequence contains at least one
A ATCTGT sequence units.
2. the identification method of marine bacteriophage Syn5 RNA polymerase transcription terminator as described in claim 1, feature exist
In containing following steps:
(1) foreign gene is inserted at the multiple cloning sites of carrier, and the promoter sequence in the carrier is replaced with into ocean
Bacteriophage Syn5 promoter sequence obtains recombinant vector;The recombinant vector is subjected to digestion using restriction enzyme, is obtained
The recombinant vector of linearisation;
(2) the outer responsive transcription system of construct, the in-vitro transcription reaction system is with the recombinant vector of step (1) linearisation
As template, using bacteriophage Syn5 RNA polymerase as RNA polymerase, with tetra- kinds of ribonucleoside triphosphotes of ATP, GTP, CTP and UTP
As raw material, make the outer responsive transcription of the recombinant vector generating body of the linearisation;DNA enzymatic is added to eliminate as the linear of template
The recombinant vector of change, the RNA product that then purifying transcription obtains;
(3) the RNA product for obtaining step (2) carries out gel electrophoresis, and the RNA product other than the RNA of recycling overall length transcription is gone forward side by side
3 ' RACE of row is sequenced, and the corresponding termination site of RNA product other than the RNA of the overall length transcription contains at least one ATCTGT
Sequence units contain at least one ATCTGT sequence list to get to marine bacteriophage Syn5 RNA polymerase transcription terminator
Member.
3. identification method as claimed in claim 2, which is characterized in that step (1) carrier is pET28b, step (1) institute
Stating restriction enzyme is restriction enzyme BglII.
4. identification method as claimed in claim 2, which is characterized in that step (2) time that reaction is transcribed in vitro is 1h-
2h。
5. identification method as claimed in claim 2, which is characterized in that step (2) the bacteriophage Syn5 RNA polymerase exists
The concentration being transcribed in vitro in reaction system is 1 μ Μ -2 μ Μ.
6. identification method as claimed in claim 2, which is characterized in that the recombinant vector of step (2) described linearisation is in vitro
Concentration in responsive transcription system is 20ng/ul-40ng/ul.
7. identification method as claimed in claim 2, which is characterized in that also wrapped in step (2) the in-vitro transcription reaction system
Include RNase inhibitor.
8. identification method as claimed in claim 2, which is characterized in that also wrapped in step (2) the in-vitro transcription reaction system
Include Tris-HCl buffer, MgCl2, spermidine, dithiothreitol (DTT) and pyrophosphatase.
9. marine bacteriophage Syn5 RNA polymerase transcription terminator as described in claim 1 is in RNA synthetic biology
Using.
10. application as claimed in claim 9, which is characterized in that the application is to be inserted into the bacteriophage in transcription templates
Syn5 RNA polymerase transcription terminator is in transcription templates by the bacteriophage to terminate responsive transcription or the application
Syn5 RNA polymerase transcription terminator carries out same sense mutation to continue responsive transcription.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811067462.XA CN109385410A (en) | 2018-09-13 | 2018-09-13 | Bite the RNA polymerase termination sequence and its identification method and application of Jun body Syn5 in ocean |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811067462.XA CN109385410A (en) | 2018-09-13 | 2018-09-13 | Bite the RNA polymerase termination sequence and its identification method and application of Jun body Syn5 in ocean |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109385410A true CN109385410A (en) | 2019-02-26 |
Family
ID=65418881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811067462.XA Pending CN109385410A (en) | 2018-09-13 | 2018-09-13 | Bite the RNA polymerase termination sequence and its identification method and application of Jun body Syn5 in ocean |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109385410A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101001951A (en) * | 2004-08-02 | 2007-07-18 | 巴斯福植物科学有限公司 | Method for isolation of transcription termination sequences |
-
2018
- 2018-09-13 CN CN201811067462.XA patent/CN109385410A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101001951A (en) * | 2004-08-02 | 2007-07-18 | 巴斯福植物科学有限公司 | Method for isolation of transcription termination sequences |
Non-Patent Citations (2)
Title |
---|
BIN ZHU等: "The RNA Polymerase of Marine Cyanophage Syn5", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 * |
XING ZHANG等: "Multiple Roles of T7 RNA Polymerase and T7 Lysozyme During Bacteriophage T7 Infection", 《J. MOL. BIOL.》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230295709A1 (en) | Linear double stranded dna coupled to a single support or a tag and methods for producing said linear double stranded dna | |
CN113699135B (en) | Adenine base editor fusion protein without PAM limitation and application thereof | |
US9012183B2 (en) | Use of template switching for DNA synthesis | |
US10465221B2 (en) | Genomically recoded organisms lacking release factor 1 (RF1) and engineered to express a heterologous RNA polymerase | |
CN108018271B (en) | Single subunit RNA polymerase, its purification method and application in RNA synthesis | |
WO2021259057A1 (en) | Method for preparing recombinant eukaryotic mrna by using prokaryotic transcription system and application thereof | |
KR20240055073A (en) | Class II, type V CRISPR systems | |
WO2010005365A1 (en) | Unprocessed rolling circle amplification product | |
CN109355290B (en) | Plant circular RNA expression frame and application thereof | |
CN111979255B (en) | Low-temperature high-yield single subunit RNA polymerase, and purification method and application thereof | |
JP2006526985A (en) | Method and kit for mass production of dsRNA | |
CN109385410A (en) | Bite the RNA polymerase termination sequence and its identification method and application of Jun body Syn5 in ocean | |
CN109055378B (en) | Production application of single-subunit RNA polymerase KP34RP in long-chain mRNA synthesis | |
JP2022522397A (en) | How to Regularly Build Circular and Linear DNA Molecules | |
CN111117942A (en) | Genetic engineering bacterium for producing lincomycin and construction method and application thereof | |
CA2285633C (en) | Bacterial plasmids | |
CN109306373B (en) | Joint, primer group and kit for detecting human genome maturation tRNA (transfer ribonucleic acid) spectrum | |
CN106834293B (en) | Circular RNA with molecular marker and preparation method and application thereof | |
JP2023505188A (en) | nucleic acid composition | |
CN104131017A (en) | Rhodotorula glutinis phenylalanine deaminase gene and application thereof | |
US20100297773A1 (en) | Expression cassette, use of the expression cassette, vector, host cell, a method for producing a polypeptide | |
WO2017215174A1 (en) | Marine bacterial gene lfliz and use | |
US20050181395A1 (en) | Systems for tightly regulated gene expression | |
CN114480464B (en) | Double plasmid construction method of vibrio parahaemolyticus CRISPRi | |
CN111979225B (en) | Application of low-temperature VSW3 RNA polymerase in-vitro transcription synthesis of full-length uninterrupted cas9 mRNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190226 |
|
RJ01 | Rejection of invention patent application after publication |